Browsing Category
Patent Expirations
1 post
Private-Public Drug Deal Enables Generic Production Of Expensive Cancer Medicine – the case of “Nilotinib” that costs $ 9,000/month in the US
Health Policy WatchKerry Cullinan20/10/2022 Site Editor: Joaquim Cardoso MSchealth transformation — institute for research and strategyOctober 20, 2022 A precedent-setting…
